225 related articles for article (PubMed ID: 12548383)
1. Effects of anticonvulsants on GLUT1-mediated glucose transport in GLUT1 deficiency syndrome in vitro.
Klepper J; Flörcken A; Fischbarg J; Voit T
Eur J Pediatr; 2003 Feb; 162(2):84-9. PubMed ID: 12548383
[TBL] [Abstract][Full Text] [Related]
2. The effects of phenytoin and its metabolite 5-(4-hydroxyphenyl)-5-phenylhydantoin on cellular glucose transport.
Wong HY; Chu TS; Chan YW; Fok TF; Fung LW; Fung KP; Ho YY
Life Sci; 2005 Mar; 76(16):1859-72. PubMed ID: 15698863
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis and anticonvulsant therapy in two patients with glucose transporter 1 deficiency syndrome: a successful use of zonisamide for controlling the seizures.
Takahashi S; Ohinata J; Suzuki N; Amamiya S; Kajihama A; Sugai R; Araki A; Fujieda K; Tanaka H
Epilepsy Res; 2008 Jul; 80(1):18-22. PubMed ID: 18455367
[TBL] [Abstract][Full Text] [Related]
4. Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome.
Coman DJ; Sinclair KG; Burke CJ; Appleton DB; Pelekanos JT; O'Neil CM; Wallace GB; Bowling FG; Wang D; De Vivo DC; McGill JJ
J Paediatr Child Health; 2006 May; 42(5):263-7. PubMed ID: 16712556
[TBL] [Abstract][Full Text] [Related]
5. Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitro.
Ho YY; Yang H; Klepper J; Fischbarg J; Wang D; De Vivo DC
Pediatr Res; 2001 Aug; 50(2):254-60. PubMed ID: 11477212
[TBL] [Abstract][Full Text] [Related]
6. Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively.
Klepper J; Scheffer H; Leiendecker B; Gertsen E; Binder S; Leferink M; Hertzberg C; Näke A; Voit T; Willemsen MA
Neuropediatrics; 2005 Oct; 36(5):302-8. PubMed ID: 16217704
[TBL] [Abstract][Full Text] [Related]
7. Human erythrocyte sugar transport is incompatible with available carrier models.
Cloherty EK; Heard KS; Carruthers A
Biochemistry; 1996 Aug; 35(32):10411-21. PubMed ID: 8756697
[TBL] [Abstract][Full Text] [Related]
8. Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome.
Klepper J; Diefenbach S; Kohlschütter A; Voit T
Prostaglandins Leukot Essent Fatty Acids; 2004 Mar; 70(3):321-7. PubMed ID: 14769490
[TBL] [Abstract][Full Text] [Related]
9. [The ketogenic diet in German-speaking countries: update 2003].
Klepper J; Leiendecker B; Riemann E; Baumeister FA
Klin Padiatr; 2004; 216(5):277-85. PubMed ID: 15455294
[TBL] [Abstract][Full Text] [Related]
10. Deficient transport of dehydroascorbic acid in the glucose transporter protein syndrome.
Klepper J; Vera JC; De Vivo DC
Ann Neurol; 1998 Aug; 44(2):286-7. PubMed ID: 9708557
[TBL] [Abstract][Full Text] [Related]
11. Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain-- a review.
Klepper J; Voit T
Eur J Pediatr; 2002 Jun; 161(6):295-304. PubMed ID: 12029447
[TBL] [Abstract][Full Text] [Related]
12. GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitro.
Klepper J; Fischbarg J; Vera JC; Wang D; De Vivo DC
Pediatr Res; 1999 Dec; 46(6):677-83. PubMed ID: 10590023
[TBL] [Abstract][Full Text] [Related]
13. Regulation of GLUT1-mediated sugar transport by an antiport/uniport switch mechanism.
Cloherty EK; Diamond DL; Heard KS; Carruthers A
Biochemistry; 1996 Oct; 35(40):13231-9. PubMed ID: 8855962
[TBL] [Abstract][Full Text] [Related]
14. T295M-associated Glut1 deficiency syndrome with normal erythrocyte 3-OMG uptake.
Fujii T; Morimoto M; Yoshioka H; Ho YY; Law PP; Wang D; De Vivo DC
Brain Dev; 2011 Apr; 33(4):316-20. PubMed ID: 20630673
[TBL] [Abstract][Full Text] [Related]
15. Glucose transporter 1 deficiency syndrome and other glycolytic defects.
De Vivo DC; Leary L; Wang D
J Child Neurol; 2002 Dec; 17 Suppl 3():3S15-23; discussion 3S24-5. PubMed ID: 12597052
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation, EEG studies, and novel mutations in two cases of GLUT1 deficiency syndrome in Japan.
Ito Y; Gertsen E; Oguni H; Nakayama T; Matsuo M; Funatsuka M; Voit T; Klepper J; Osawa M
Brain Dev; 2005 Jun; 27(4):311-7. PubMed ID: 15862198
[TBL] [Abstract][Full Text] [Related]
17. Properties of the human erythrocyte glucose transport protein are determined by cellular context.
Levine KB; Robichaud TK; Hamill S; Sultzman LA; Carruthers A
Biochemistry; 2005 Apr; 44(15):5606-16. PubMed ID: 15823019
[TBL] [Abstract][Full Text] [Related]
18. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects.
Wang D; Pascual JM; Yang H; Engelstad K; Jhung S; Sun RP; De Vivo DC
Ann Neurol; 2005 Jan; 57(1):111-8. PubMed ID: 15622525
[TBL] [Abstract][Full Text] [Related]
19. Bench meets bedside: a 10-year-old girl and amino acid residue glycine 75 of the facilitative glucose transporter GLUT1.
Klepper J; Salas-Burgos A; Gertsen E; Fischbarg J
Biochemistry; 2005 Sep; 44(38):12621-6. PubMed ID: 16171377
[TBL] [Abstract][Full Text] [Related]
20. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier.
Seidner G; Alvarez MG; Yeh JI; O'Driscoll KR; Klepper J; Stump TS; Wang D; Spinner NB; Birnbaum MJ; De Vivo DC
Nat Genet; 1998 Feb; 18(2):188-91. PubMed ID: 9462754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
